News | Blood Testing | September 04, 2018

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

Prevencio’s multi-protein, AI-driven HART PAD biomarker test has potential to improve clinical outcomes and reduce costs in the treatment of diabetic patients

AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient

September 4, 2018 — Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD) in diabetes mellitus (DM) patients, a patient population in which PAD prevalence has traditionally been difficult to assess. Researchers believe these findings, presented at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-28 in Munich, Germany, could lead to early identification of PAD and improve patient clinical outcomes, as well as prevent patients without PAD from undergoing unnecessary, expensive and invasive tests.

The study is follow-on to data presented at the American Diabetes Association (ADA) 2018 Scientific Sessions in June demonstrating Prevencio’s HART CAD and HART CVE tests accurately diagnose coronary artery disease (CAD) and predict the risk for major adverse cardiac events (MACE) in DM patients. Similar to CAD, PAD is commonly due to atherosclerosis, a plaque buildup in the arteries which restricts blood flow.

In this study, researchers assessed the company’s artificial intelligence (AI)-driven HART PAD diagnostic test on patients enrolled in Massachusetts General Hospital’s (MGH) Catheter Sampled Blood Archive in Cardiovascular Disease (CASABLANCA) study. The HART PAD test algorithmically assesses six biomarkers linked to atherosclerosis, as well as a patient’s history of hypertension. In patients with DM, the HART PAD panel had excellent performance for diagnosis of PAD. Using a five-point score, a score of 1 had a 100 percent negative predictive value (NPV) and a score of 5 had a 95 percent positive predictive value (PPV). Additionally, the HART PAD panel was highly accurate in predicting the need for revascularization in patients with PAD. These results were comparable to those patients without DM.

Principal investigator James L. Januzzi, M.D., practicing cardiologist at MGH and professor of medicine at Harvard Medical School, said, “The HART PAD test may allow for the diagnosis and treatment of many more patients with currently undetected PAD. In the clinical setting, these findings could assist physicians to identify peripheral artery disease earlier, provide guideline-recommended care and monitor at-risk patients for vascular complications. We believe HART tests could also play an important role in identifying high-risk patients for enrollment in clinical trials, thereby saving time and lowering overall trial costs.”

PAD affects more than 202 million people worldwide and is often underdiagnosed and undertreated until the disease has reached advanced stages. Patients with DM are at substantial risk of developing PAD. Patients with PAD have increased risk of CAD, heart attack or stroke and, if left untreated, PAD can lead to foot or leg amputation.

For more information: www.prevenciomed.com


Related Content

News | Artificial Intelligence

January 27, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI ...

Home January 27, 2023
Home
News | Artificial Intelligence

December 19, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered ...

Home December 19, 2022
Home
News | Artificial Intelligence

December 19, 2022 — As a leader in vascular care, Delray Medical Center is the first hospital in Florida to acquire the ...

Home December 19, 2022
Home
News | Artificial Intelligence

December 12, 2022 — US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza ...

Home December 12, 2022
Home
News | Artificial Intelligence

November 23, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today ...

Home November 23, 2022
Home
News | Artificial Intelligence

November 21, 2022 — Artificial intelligence can improve diagnosis and treatment for patients, but first the AI-enabled ...

Home November 21, 2022
Home
News | Artificial Intelligence

November 16, 2022 — Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today ...

Home November 16, 2022
Home
News | Artificial Intelligence

November 16, 2022 — A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect ...

Home November 16, 2022
Home
News | Artificial Intelligence

September 29, 2022 — Researchers at Mayo Clinic used artificial intelligence (AI) to evaluate patients’ ...

Home September 29, 2022
Home
News | Artificial Intelligence

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech ...

Home September 22, 2022
Home
Subscribe Now